Preconceived notions about biosimilars—a French experience - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Clinical Rheumatology Année : 2020

Preconceived notions about biosimilars—a French experience

Résumé

Since the arrival of the first biosimilar monoclonal antibodies into the market, many information has been circulating, leading to preconceived notions for patients and healthcare professionals. In a pressing economic context and faced with a growing number of available biosimilars, we (clinician, patient association, biologist, pharmacists, health economists) propose to take stock by trying to distinguish facts from misconceptions.

Domaines

Droit

Dates et versions

hal-03636664 , version 1 (11-04-2022)

Identifiants

Citer

Jean-David Cohen, Sonia Tropé, Pascal Paubel, Audrey Munos, François Bocquet. Preconceived notions about biosimilars—a French experience. Clinical Rheumatology, 2020, 39 (8), pp.2251-2254. ⟨10.1007/s10067-020-05229-7⟩. ⟨hal-03636664⟩
15 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More